What We Looked At
We scraped and analyzed 9,170 on-site reviews via the Okendo reviews API (4.86 average stars, 90.5% five-star, dating from August 2020 to March 2026), 36 Trustpilot reviews (4.1 stars), all five product listings (Shopify JSON), clinical study pages for both the Liver and Cholesterol products, the Scientific Advisory Board page, social presence (Facebook, Instagram, TikTok), Amazon (no active listings found), subscription model with free wellness coach, and the competitive landscape of liquid liver supplements. The review corpus is rich: “liver enzymes” appears 5,427 times, “taste/flavor” 4,187 times, “energy” 889 times, “morning routine” 776 times, “blood work” 548 times, “digestion” 398 times, “bloating” 339 times, and “alcohol” 294 times.
Clinical Data That Sells Itself — If You Let It
Dose for Your Liver is a liquid herbal supplement built on five active ingredients: Curcumin, Dandelion, Ginger, Milk Thistle, and Orange. The clinical data is the headline: 50% decrease in AST levels and 52% decrease in ALT levels after 8 weeks. Those are liver enzyme markers that doctors order in standard bloodwork. When a customer says “my doctor said I was heading towards cirrhosis… 2 months later the fatty liver was GONE,” that’s not a supplement testimonial. That’s a medical outcome story that the entire liver health market is searching for.
The product has massive traction: 9,170 verified on-site reviews averaging 4.86 stars (90.5% five-star), a subscription model with a free wellness coach, a 4-person Scientific Advisory Board (including a research microbiologist and an interventional cardiologist), and two clinical study pages. The reviews span nearly 6 years (August 2020 to March 2026). When Dose works, it works dramatically — Stacey went from ALT 167 / AST 125 to ALT 21 / AST 24 after taking Dose. Amanda H. normalized her liver enzymes after 30 days and avoided a liver biopsy. Chris G. went from being denied health insurance due to liver damage from a decade of heavy drinking to “every single number on my labs was perfect.” The 153 mentions of subscription complaints across 9,170 reviews (1.7%) represent a real friction point, but the signal-to-noise ratio is overwhelmingly positive.
What the Brand Says vs. What Customers Say
“I don’t know how to explain how this product has changed my life in as little as 30 days. If your liver needs help, PLEASE DO NOT MISS OUT ON THIS. I have so much energy. I feel such a transformation. I want to scream it at the top of my lungs and tell all my loved ones to get this. I would even do ads for this product if they asked me to.”
Ashley C. — Verified Buyer, February 2025The gap between Dose’s positioning (“Support Your Body’s Core Systems”) and its best customer stories (“My fatty liver was GONE”) is enormous. The brand leads with clinical percentages. The customers lead with transformation narratives. The clinical data should be the evidence. The customer stories should be the headline. Every market identified below responds more to “my liver numbers went from dangerous to normal” than to “50% decrease in AST levels.” Both say the same thing. One of them makes you feel something.
Four Markets, One Liver
Non-alcoholic fatty liver disease (NAFLD) affects an estimated 100 million Americans — roughly 1 in 3 adults. Most discover it the same way: routine bloodwork shows elevated AST and ALT levels. The doctor says “your liver enzymes are high — you need to make lifestyle changes.” The patient Googles “how to lower liver enzymes naturally.” That search is the top of Dose’s funnel, and it generates millions of queries per year.
Dose’s clinical data — 50% AST decrease and 52% ALT decrease after 8 weeks — speaks directly to this audience in the language they already understand. When one Trustpilot reviewer writes “Had elevated liver enzymes on blood work for many, many years. After taking Dose for liver… for the first time in more years than I can remember, the liver bloodwork was normal,” that review is worth more than any ad campaign. It’s the exact outcome this audience is searching for, in the exact words they would use.
Don’t lead with “support your body’s core systems.” Lead with the doctor visit. Lead with the bloodwork. Lead with the anxiety of elevated numbers. Then show the data: 50% AST decrease. 52% ALT decrease. 8 weeks. That’s the story this audience needs to hear.
Works Alongside (Not Against)
Buyer Types in This Market
Angles That Work Here
What They Say (from 9,170 Okendo Reviews)
“Bloodwork during a routine physical in 2022 showed my liver enzymes to be high… ALT @ 167, AST @ 125. I began taking Dose for Liver in June of 2024. I went back for bloodwork mid-September and my ALT is now 21 and my AST is now 24! My doctor was amazed at the drastic improvement!”
Stacey — Verified Buyer, October 2024“I originally purchased it because my liver enzymes were elevated, and my liver was enlarged. As of May 23rd my liver enzymes have completely normalized… If I hadn’t lowered my enzymes I was going to have to have a liver biopsy, and now that my levels have normalized I don’t have to. That is such a huge deal to me!”
Amanda H. — Verified Buyer, June 2022“I unfortunately received some concerning lab work indicating elevated AST, ALT and A1C levels… Rather than going on Ozempic, I decided to try a natural approach and found Dose for Your Liver… my labs indicated a 52% reduction in AST and 56% reduction in ALT levels. My A1C level also went down 6%.”
Kevin — Verified Buyer, February 2024A Trustpilot reviewer revealed something powerful: “My doctor a year and half ago put me on Ozempic, the only thing it did was make me lose my gallbladder. My liver has taken a beating over it.” This person turned to Dose specifically because a popular medication damaged their liver. They’re not alone. GLP-1 receptor agonists (Ozempic, Wegovy, Mounjaro) are now prescribed to over 30 million Americans. Statins are prescribed to over 40 million. Both drug classes can elevate liver enzymes. And a growing number of patients are looking for natural liver support alongside or after these medications.
This is a massive and largely untapped positioning opportunity. The “post-Ozempic liver recovery” audience didn’t exist two years ago. Now it’s enormous, growing, and actively searching for solutions. The same is true for the “statin liver support” audience and the “alcohol recovery liver support” audience. These are people whose livers are under specific, known stress from a specific, known source. Dose’s ingredient stack (curcumin, milk thistle, dandelion, ginger) maps directly to the traditional and clinical evidence for liver support in these contexts.
Position Dose as the liver support complement to the medications people are already taking. Not anti-medication. Pro-liver. The message: your prescription does its job. Dose does the liver’s.
Buyer Types in This Market
Angles That Work Here
What They Say
“I’m 39. I started to drink hard around 28 years old… Combined with cutting out all alcohol for a year my labs were so perfect the doctor didn’t even know how to answer my questions about my numbers. All she could say is that every single number on my labs was perfect and consistent with a healthy functioning system even after I told her how I drank and for how long.”
Chris G. — Verified Buyer, January 2024“My doctor a year and half ago put me on Ozempic, the only thing it did was make me lose my gallbladder. My liver has taken a beating over it. I started to use Dose for a healthier liver and it worked wonderfully.”
Trustpilot — Verified Review, November 2025Several Dose reviews mention a benefit the brand barely markets: relief from bloating and inflammation. “I’ve always had bad bloating and inflammation… since Dose I feel unbelievable, my stomach has gotten so much better, no bloating, more energy.” Another reviewer notes it “helps with body inflammation and your gut.” These aren’t liver-specific outcomes — they’re digestive wellness outcomes driven by the curcumin and ginger in the formula.
The bloating and inflammation market is enormous: 74% of Americans report living with digestive discomfort, and bloating is the #1 gastrointestinal complaint. Curcumin is one of the most studied anti-inflammatory compounds in nutritional science. Ginger is one of the most established digestive aids. Dose already contains both. The liquid delivery format is a structural advantage for this audience — people with digestive issues often have trouble with pills and capsules. A liquid that “tastes like orange juice” and also reduces bloating is a fundamentally different proposition than another capsule.
Reframe the product from “liver supplement” to “morning anti-bloating ritual.” The liver benefits remain. But the daily, felt benefit — reduced bloating — is what drives the habit and the reorder.
Buyer Types in This Market
What They Say (339 Reviews Mention Bloating)
“Just after 2 months I already feel so much better! I have more energy, no more bloating, I unexpectedly lost some weight. I can’t say enough good things about this product!”
Krista A. — Verified Buyer, April 2025“So far I’m really enjoying the Dose. I feel like inflammation is settling down, skin is looking better and my joints feel a little better. The taste is great. My son is also drinking it daily for stomach issues.”
Heather K. — Verified Buyer, January 2026Dose’s liquid format isn’t a nice-to-have. It’s a structural competitive advantage that the brand underplays. The supplement industry is overwhelmingly pill and capsule-based. The average health-conscious consumer takes 4+ supplements daily. Compliance drops dramatically with pill fatigue — people stop taking supplements because swallowing another capsule feels like a chore. A liquid that “tastes like orange juice” and replaces a handful of pills (curcumin + milk thistle + ginger + dandelion in one shot) is a fundamentally better user experience.
The product page mentions this (“Let’s be honest — swallowing big, chalky pills isn’t enjoyable”) but buries it below the fold. For the pill-fatigued consumer, this IS the headline. They’re not comparing Dose to other liver supplements. They’re comparing it to their entire pill stack. “Replace 4 capsules with 1 shot that tastes like orange juice” is a product truth that converts on format alone.
For the person who is tired of swallowing pills: Dose replaces curcumin, milk thistle, ginger, and dandelion capsules with a single liquid shot. The compliance advantage IS the product advantage.
Buyer Types in This Market
Side by Side
| Market | Current Presence | Evidence Strength | Market Size | Top Angle |
|---|---|---|---|---|
| Elevated Enzyme / Fatty Liver | Clinical data on page (undersold) | Very strong | 100M+ Americans with NAFLD | “Doctor Said Numbers Are High” |
| Post-Medication Liver Support | Not addressed | Strong (Ozempic review + growing need) | 30M+ GLP-1 users, 40M+ statin | “On Ozempic? Your Liver Needs This.” |
| Bloating & Inflammation | Mentioned in reviews, not marketed | Moderate (real reviews, no clinical data) | Very large (74% of Americans) | “The Shot That Unfloats Your Day” |
| Pill-Fatigued Consumers | On page but buried below fold | Moderate (format advantage clear) | Large, structural | “One Shot. No Pills. Tastes Like Juice.” |
The review moat is real: We scraped 9,170 verified reviews via the Okendo API — significantly more than the “5,000+” claimed on the homepage (they’re underselling themselves). The rating distribution is healthy: 90.5% five-star, 7.1% four-star, 1.4% three-star, 0.5% two-star, 0.6% one-star. Reviews span nearly 6 years. The keyword analysis reveals a product that people use for liver enzyme reduction (5,427 mentions), love the taste of (4,187 mentions), integrate into their morning routine (776 mentions), and rely on for energy (889 mentions). The 153 subscription-related complaints are real but represent 1.7% of all reviews — manageable friction, not a crisis. The external trust gap remains: only 36 Trustpilot reviews vs. 9,170 on-site. Pushing more customers to Trustpilot and launching on Amazon would extend this social proof beyond the DTC site.
What the Negative Reviews Tell You
Sizing Confusion
“Ordered thinking I had ordered a 3 month supply. Instead I just paid $90 for a 3 week supply.” This is the #1 complaint. The 16oz 3-Pack at $90 is perceived as a 3-month supply but lasts ~3 weeks at the recommended dose. The pricing page needs clearer “X days of supply” labeling on every variant. Confusion ≠ deception, but the customer doesn’t make that distinction.
Subscription Cancellation
“It appears more difficult to cancel a subscription than I initially thought.” In the supplement subscription space, easy cancellation paradoxically increases LTV. Customers who feel trapped churn angry and leave negative reviews. Customers who can cancel easily often come back. Make cancellation frictionless and add a “skip a month” option.
Efficacy Variance
“Took it for almost a year. Didn’t really notice a difference.” This is normal for herbal supplements — not everyone responds the same way. The solution isn’t hiding this. It’s setting expectations: “Try for 8 weeks. Get retested. If your numbers don’t improve, we’ll refund you.” A results-based guarantee converts skeptics and filters for the audience most likely to succeed.
Three Moves That Require Zero Product Changes
Lead with Customer Stories, Back with Data
The homepage leads with “50% decrease in AST.” That’s evidence, not emotion. Flip the hierarchy: lead with “My fatty liver was GONE after 2 months” (customer story), then back it with “Clinical study: 50% AST decrease in 8 weeks” (evidence). Story creates connection. Data creates confidence. In that order. The customers are already writing the headlines — use them.
Fix Sizing Transparency and Subscription UX
Add “X days of daily doses” to every variant label. A 3-Pack that lasts 21 days should say “21-Day Supply” not “3 Pack.” Add one-click subscription cancellation and a “skip a month” option. These changes cost almost nothing to implement and directly address the two most common complaints in the Trustpilot reviews. Trust in supplements is fragile. Protect it.
Launch Amazon with the 2oz 24-Pack
Dose has zero Amazon presence for a product category that Amazon dominates. The 2oz single-serve 24-pack ($99) is the ideal Amazon SKU: it’s Subscribe & Save compatible, it ships easily, and the single-serve format has inherent impulse appeal. Target keywords: “liver supplement liquid,” “milk thistle liquid,” “curcumin liquid,” “liver detox supplement.” The clinical data and existing reviews become the Amazon listing’s competitive advantage over commodity capsules.
How to Validate These Discoveries
Test the “elevated enzyme” market first. This audience is actively searching for solutions, has a measurable outcome they’re tracking (AST/ALT levels), and Dose has the strongest evidence for this specific use case. Build a landing page that leads with the doctor-visit moment: “Your doctor said your liver numbers are high. Here’s what happened to ours after 8 weeks.” Show the clinical data. Show the customer stories. Show the 8-week timeline. The conversion path is clear: buy → take for 8 weeks → retest → see results → subscribe.
Build the “post-Ozempic liver support” angle as a separate campaign. This is a new audience that didn’t exist two years ago. The targeting is precise (GLP-1 users, weight loss medication communities, Ozempic side effects). The Trustpilot review about post-Ozempic liver damage is the seed creative. Test it as a video testimonial: “Ozempic helped with weight. It didn’t help my liver. Here’s what did.”
Migrate reviews to verifiable platforms. 5,000+ claimed reviews should generate hundreds of Trustpilot reviews, dozens of Amazon reviews, and a connected on-site review widget (Judge.me, Yotpo, or Okendo) that can be independently verified. The gap between 5,000+ and 36 verifiable reviews is a credibility risk. Close it. Every verified review from a real customer with a real liver-number improvement story is worth exponentially more than a claimed review count.
What we didn’t include: This analysis is based on 9,170 scraped Okendo reviews, 36 Trustpilot reviews, Shopify product data, clinical study pages, and competitive landscape analysis. With first-party data (customer bloodwork before/after results, subscription retention rates, NPS, refund rates, ad account performance, and variant-level sales data), we could identify which clinical claim drives the highest conversion, what percentage of subscribers see measurable liver improvement, which market segment has the best LTV-to-CAC ratio, and whether the 16oz bottles or 2oz shots drive higher subscription retention.